Published in Lancet on June 14, 1980
Triggering infections in reactive arthritis. Ann Rheum Dis (1985) 1.36
Rapid detection of Campylobacter jejuni in stool specimens by an enzyme immunoassay and surveillance for Campylobacter upsaliensis in the greater Salt Lake City area. J Clin Microbiol (2000) 1.31
Campylobacter enteritis in Denver. West J Med (1982) 1.23
B27 positive diseases versus B27 negative diseases. Ann Rheum Dis (1988) 0.90
Decomplementation by cobra venom factor suppresses Yersinia-induced arthritis in rats. Infect Immun (1995) 0.86
Reactive arthritis. Postgrad Med J (1982) 0.82
Bartonella henselae associated uveitis and HLA-B27. Br J Ophthalmol (2000) 0.80
Campylobacter enterocolitis: general and surgical aspects. Postgrad Med J (1986) 0.80
Campylobacter jejuni enteritis and reactive arthritis. Ann Rheum Dis (1982) 0.79
Reiter's syndrome in association with enteritis due to Campylobacter fetus ssp. jejuni. Ann Rheum Dis (1981) 0.77
Various rheumatic syndromes in adult patients associated with high antistreptolysin O titres and their differential diagnosis with rheumatic fever. Ann Rheum Dis (1993) 0.77
Campylobacteremia in stage IV gliosarcoma with bevacizumab treatment. J Community Hosp Intern Med Perspect (2012) 0.75
Rabbit antisera against three different bacteria which can induce reactive arthritis: analysis by ELISA, immunoprecipitation and Western Blot. Immunology (1985) 0.75
Methodological issues in studies of air pollution and daily counts of deaths or hospital admissions. J Epidemiol Community Health (1996) 4.44
Short term effects of air pollution on health: a European approach using epidemiologic time series data: the APHEA protocol. J Epidemiol Community Health (1996) 3.90
An international outbreak of Salmonella infections caused by alfalfa sprouts grown from contaminated seeds. J Infect Dis (1997) 3.39
Short-term effects of air pollution on health: a European approach using epidemiological time-series data. The APHEA project: background, objectives, design. Eur Respir J (1995) 3.19
Effect of long term consumption of probiotic milk on infections in children attending day care centres: double blind, randomised trial. BMJ (2001) 2.91
Serological markers and HLA genes among healthy first-degree relatives of patients with coeliac disease. Lancet (1991) 2.76
Time-series analysis of air pollution and cause-specific mortality. Epidemiology (1998) 2.60
EB virus-induced B lymphocyte cell lines producing specific antibody. Nature (1977) 2.56
Ten year mortality and causes of death in patients with rheumatoid arthritis. Br Med J (Clin Res Ed) (1985) 2.10
Compositional analysis of Helicobacter pylori rough-form lipopolysaccharides. J Bacteriol (1992) 1.98
Role of metronidazole resistance in therapy of Helicobacter pylori infections. Antimicrob Agents Chemother (1992) 1.92
Effect of long-term consumption of a probiotic bacterium, Lactobacillus rhamnosus GG, in milk on dental caries and caries risk in children. Caries Res (2002) 1.92
Helicobacter pylori infection and chronic gastritis in gastric cancer. J Clin Pathol (1992) 1.76
Normal small bowel biopsy followed by coeliac disease. Arch Dis Child (1990) 1.74
Emergence of fluoroquinolone resistance in Campylobacter jejuni and Campylobacter coli in subjects from Finland. Antimicrob Agents Chemother (1991) 1.72
Low biological activity of Helicobacter pylori lipopolysaccharide. Infect Immun (1992) 1.71
An acid extract as a common antigen in Campylobacter coli and Campylobacter jejuni strains. J Clin Microbiol (1983) 1.65
Serology of Campylobacter fetus ss. jejuni )"related" campylobacters). Demonstration of strain-specific and interstrain-related antigens by immunoelectrophoresis and co-agglutination. Acta Pathol Microbiol Scand B (1980) 1.64
Helicobacter pylori induces lymphocyte activation in peripheral blood cultures. Clin Exp Immunol (1990) 1.62
Short-term effects of air pollution on hospital admissions of respiratory diseases in Europe: a quantitative summary of APHEA study results. Air Pollution and Health: a European Approach. Arch Environ Health (1998) 1.59
Questionable specificity of lipid antigen in the Mycoplasma pneumoniae complement fixation test in patients with extrapulmonary manifestations. J Infect (1981) 1.58
Salmonella in alfalfa sprouts. Lancet (1995) 1.52
Chemical characterization of Campylobacter jejuni lipopolysaccharides containing N-acetylneuraminic acid and 2,3-diamino-2,3-dideoxy-D-glucose. J Bacteriol (1991) 1.46
Intraepithelial gamma delta T-cell-receptor lymphocytes and genetic susceptibility to coeliac disease. Lancet (1992) 1.45
Evidence that cagA(+) Helicobacter pylori strains are disappearing more rapidly than cagA(-) strains. Gut (2002) 1.43
Prolonged campylobacter gastroenteritis in a patient with hypogammaglobulinaemia. Acta Med Scand (1983) 1.41
Campylobacter enteritis in 188 hospitalized patients. Arch Intern Med (1983) 1.41
Triggering infections in reactive arthritis. Ann Rheum Dis (1985) 1.36
Central nervous system manifestations associated with serologically verified Mycoplasma pneumoniae infection. Scand J Infect Dis (1980) 1.32
The prevalence of narcolepsy: an epidemiological study of the Finnish Twin Cohort. Ann Neurol (1994) 1.32
The occurrence and clinical picture of serologically verified Mycoplasma pneumoniae infections with emphasis on central nervous system, cardiac and joint manifestations. Ann Clin Res (1979) 1.31
Serology of Campylobacter fetus ss. jejuni. 2 Serotyping of live bacteria by slide, latex and co-agglutination tests. Acta Pathol Microbiol Immunol Scand B (1982) 1.30
Arthritis associated with Campylobacter jejuni enteritis. Scand J Rheumatol (1981) 1.27
Risk factors for mortality in Type II (non-insulin-dependent) diabetes: evidence of a role for neuropathy and a protective effect of HLA-DR4. Diabetologia (1998) 1.25
Celiac disease in insulin-dependent diabetes mellitus. J Pediatr (1986) 1.24
Chemotaxis in yersinia arthritis. HLA-B27 positive neutrophils show high stimulated motility in vitro. Arthritis Rheum (1980) 1.21
Death rate and causes of death in patients with rheumatoid arthritis. Scand J Rheumatol (1975) 1.20
Reactive arthritis following an outbreak of Salmonella infection in Finland. Br J Rheumatol (1994) 1.19
Circulating anti-Helicobacter pylori immunoglobulin A antibodies and low serum pepsinogen I level are associated with increased risk of gastric cancer. Am J Epidemiol (1996) 1.18
Sulfasalazine in the treatment of ankylosing spondylitis. A twenty-six-week, placebo-controlled clinical trial. Arthritis Rheum (1988) 1.18
Inverse correlation between Helicobacter pylori infection and inflammatory bowel disease. J Clin Pathol (1996) 1.16
Campylobacter etiology in human gastroenteritis demonstrated by antibodies to acid extract antigen. J Clin Microbiol (1987) 1.16
Effect of erythromycin on the fecal excretion of Campylobacter fetus subspecies jejuni. J Infect Dis (1982) 1.16
Triple therapy of Helicobacter pylori infection in peptic ulcer. A 12-month follow-up study of 93 patients. Scand J Gastroenterol (1992) 1.16
Decreasing prevalence of helicobacter antibodies in Finland, with reference to the decreasing incidence of gastric cancer. Epidemiol Infect (2001) 1.16
Secondary failure to treatment with oral antidiabetic agents in non-insulin-dependent diabetes. Diabetes Care (1986) 1.15
Primary and secondary variants in immunoglobulin heavy chain production. Nature (1976) 1.15
Causes of death in autopsied RA patients. Scand J Rheumatol (1976) 1.13
Diagnosis of Helicobacter pylori infection in patients with atrophic gastritis: comparison of histology, 13C-urea breath test, and serology. Scand J Gastroenterol (2000) 1.13
Prognosis of inflammatory joint diseases. A three-year follow-up study. Scand J Rheumatol (1983) 1.11
Effects of probiotic therapy on the activity and activation of mild rheumatoid arthritis--a pilot study. Scand J Rheumatol (2003) 1.09
Death rate and causes of death in RA patients during a period of five years. Scand J Rheumatol (1977) 1.09
Waterborne outbreak of Campylobacter enteritis after outdoors infantry drill in Utti, Finland. Epidemiol Infect (1989) 1.08
Depression of human neutrophil motility by influenza virus in vitro. Scand J Immunol (1977) 1.06
Heterogeneity of Campylobacter pylori as demonstrated by co-agglutination testing with rabbit antibodies. Scand J Gastroenterol Suppl (1988) 1.05
Contact of lymphocytes with Helicobacter pylori augments natural killer cell activity and induces production of gamma interferon. Infect Immun (1993) 1.05
The prediction of radiological destruction during the early stage of rheumatoid arthritis. Clin Exp Rheumatol (1985) 1.05
Risk factors and markers associated with proliferative retinopathy in patients with insulin-dependent diabetes. Diabetes (1986) 1.04
The expression of autoimmune polyglandular disease type I appears associated with several HLA-A antigens but not with HLA-DR. J Clin Endocrinol Metab (1988) 1.04
High frequency of helicobacter negative gastritis in patients with Crohn's disease. Gut (1996) 1.03
Effect of ABO blood group and secretor status on the frequency of Helicobacter pylori antibodies. Scand J Gastroenterol (1990) 1.03
Clinical and serological studies in patients with Campylobacter fetus ssp. jejuni infection: II. Serological findings. Infection (1981) 1.02
Biochemical characterization of Campylobacter fetus lipopolysaccharides. Infect Immun (1994) 1.02
Rectal mucosal adrenergic innervation and enterochromaffin cells in ulcerative colitis and irritable colon. Scand J Gastroenterol (1977) 1.02
Antibodies against an acid extract from a single campylobacter strain in hospitalized campylobacter patients. Infection (1983) 1.01
Carditis and arthritis associated with Campylobacter jejuni infection. Acta Med Scand (1980) 1.01
A prospective study of the precursors to problem drinking in young adulthood. J Stud Alcohol (1994) 1.01
The effect of Helicobacter pylori eradication on the natural course of atrophic gastritis with dysplasia. Aliment Pharmacol Ther (2002) 1.01
Organ-specific autoimmunity and HLA-DR antigens as markers for beta-cell destruction in patients with type II diabetes. Diabetes (1988) 1.00
Enterochromaffin cells in macrophages in ulcerative colitis and irritable colon. Ann Clin Res (1976) 1.00
Defective chemotaxis in monosomy-7. Nature (1977) 0.99
Ribotyping patterns and emergence of metronidazole resistance in paired clinical samples of Helicobacter pylori. J Clin Microbiol (1994) 0.99
Allergy gap between Finnish and Russian Karelia on increase. Allergy (2011) 0.99
Effect of zinc sulphate on the absorption of tetracycline and doxycycline in man. Eur J Clin Pharmacol (1975) 0.98
Carditis associated with mycoplasma pneumoniae infection. Acta Med Scand (1979) 0.98
Children with newly diagnosed insulin dependent diabetes mellitus have increased levels of cow's milk antibodies. Diabetes Res (1988) 0.98
Low degree of DNA polymorphism in the HLA-linked lymphotoxin (tumour necrosis factor beta) gene. Scand J Immunol (1988) 0.98
Establishment of anti-TNP antibody-producing human lymphoid lines by preselection for hapten binding followed by EBV transformation. Scand J Immunol (1979) 0.98
Genetic susceptibility to multiple sclerosis. A co-twin study of a nationwide series. Arch Neurol (1988) 0.98
Death certificate and mortality in rheumatoid arthritis. Scand J Rheumatol (1986) 0.98
Dendritic cells in human peripheral blood: effective enrichment from the nonadherent cells. Immunol Lett (1987) 0.97